Latest Sickle-Cell Anemia news
FDA Expands Use of First Sickle Cell Disease Gene Therapy for Children as Young as 2 Years
posted July 8th
by modernClinician Editorial Team
by modernClinician Editorial Team
ASH: Iron Overload Prevalent in Sickle Cell Disease
posted December 10th
by modernClinician Editorial Team
by modernClinician Editorial Team
ASH: Late Effects Uncommon for Patients With Sickle Cell Disease After Allogeneic HCT
posted December 10th
by modernClinician Editorial Team
by modernClinician Editorial Team
ASH: No Specific Harms Found for Hydroxyurea Use During Pregnancy
posted December 9th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Maternal Night-Shift Work Tied to Later Neurodevelopmental Issues in Offspring 
Vitamin C Supplements in Pregnancy May Boost Infant Emotional Well-Being 
Excessive Gestational Weight Gain Linked to Severe Maternal Morbidity 
Treatment Satisfaction Higher for Patients With RA Choosing Their Own Treatment Related Articles
Majority of Patients in ED With Sickle Cell Crisis Not Triaged Appropriately .jpeg)
Timely Opioid Administration Cuts Hospitalizations for Pediatric Sickle Cell Crises 
Less Than Half of Youths With Sickle Cell Received Dental Services in 2022 Monthly Specialist Briefings
Stay Connected
